ADRB2 and neoplasm: Inhibition of ADRB2 can reduce the expression of target genes, including MMP9, MMP2, and vascular endothelial growth factor (VEGF), via the cAMP-dependent PKA and Ras pathways, therefore diminishing tumor invasiveness.